Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026)
Voyager Therapeutics (VYGR) EBITDA Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -124,904.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124,904.00 |
| Dec 31, 2025 | -177,940.00 |
| Sep 30, 2025 | -26,406.00 |
| Jun 30, 2025 | 201,576.00 |
| Mar 31, 2025 | 270,872.00 |
| Dec 31, 2024 | -62,814.00 |
| Sep 30, 2024 | 164,081.00 |
| Jun 30, 2024 | 205,569.00 |
| Mar 31, 2024 | 31,063.00 |
| Dec 31, 2023 | 42,299.00 |
| Sep 30, 2023 | -71,124.00 |
| Jun 30, 2023 | -48,758.00 |
| Mar 31, 2023 | 21,690.00 |
| Dec 31, 2022 | 162,685.00 |
| Sep 30, 2022 | 12,230.00 |
| Jun 30, 2022 | -274,002.00 |
| Mar 31, 2022 | -268,103.00 |
| Dec 31, 2021 | 117,375.00 |
| Sep 30, 2021 | -68,688.00 |
| Jun 30, 2021 | -110,866.00 |